SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-047071
Filing Date
2017-09-07
Accepted
2017-09-07 16:34:49
Documents
3
Period of Report
2017-09-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v474790_8k.htm 8-K 15662
2 EXHIBIT 99.1 v474790_ex99-1.htm EX-99.1 24981
3 GRAPHIC logo_001.jpg GRAPHIC 16743
  Complete submission text file 0001144204-17-047071.txt   65055
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 171074213
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1